Insulin Resistance Is Associated with Increased Serum Levels of Glycosylphosphatidylinositol-Specific Phospholipase D

Trisha A. Kurtz, Naomi S. Fineberg, Robert Considine, Mark A. Deeg

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The dyslipidemia of the metabolic syndrome is associated with alterations in triglyceride and high-density lipoprotein (HDL) metabolism. We examined the serum levels of glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD), a minor HDL-associated protein, in a cohort with a wide range of insulin sensitivity. The mean serum GPI-PLD mass from 109 subjects was 58.9 ± 18.4 μg/mL (mean ± SD). GPI-PLD levels directly correlated with cholesterol, apolipoprotein AI, triglycerides, insulin, and homeostasis model assessment (HOMA) but not C-reactive protein. These results suggest that increased serum GPI-PLD is associated with the insulin resistance.

Original languageEnglish (US)
Pages (from-to)138-139
Number of pages2
JournalMetabolism: Clinical and Experimental
Volume53
Issue number2
DOIs
StatePublished - Feb 2004
Externally publishedYes

Fingerprint

glycoprotein phospholipase D
Insulin Resistance
HDL Lipoproteins
Serum
Triglycerides
Apolipoprotein A-I
Dyslipidemias
C-Reactive Protein
Homeostasis
Cholesterol
Insulin

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Insulin Resistance Is Associated with Increased Serum Levels of Glycosylphosphatidylinositol-Specific Phospholipase D. / Kurtz, Trisha A.; Fineberg, Naomi S.; Considine, Robert; Deeg, Mark A.

In: Metabolism: Clinical and Experimental, Vol. 53, No. 2, 02.2004, p. 138-139.

Research output: Contribution to journalArticle

@article{74c8cb8be89d4661aae1d082dbd989c5,
title = "Insulin Resistance Is Associated with Increased Serum Levels of Glycosylphosphatidylinositol-Specific Phospholipase D",
abstract = "The dyslipidemia of the metabolic syndrome is associated with alterations in triglyceride and high-density lipoprotein (HDL) metabolism. We examined the serum levels of glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD), a minor HDL-associated protein, in a cohort with a wide range of insulin sensitivity. The mean serum GPI-PLD mass from 109 subjects was 58.9 ± 18.4 μg/mL (mean ± SD). GPI-PLD levels directly correlated with cholesterol, apolipoprotein AI, triglycerides, insulin, and homeostasis model assessment (HOMA) but not C-reactive protein. These results suggest that increased serum GPI-PLD is associated with the insulin resistance.",
author = "Kurtz, {Trisha A.} and Fineberg, {Naomi S.} and Robert Considine and Deeg, {Mark A.}",
year = "2004",
month = "2",
doi = "10.1016/j.metabol.2003.09.004",
language = "English (US)",
volume = "53",
pages = "138--139",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Insulin Resistance Is Associated with Increased Serum Levels of Glycosylphosphatidylinositol-Specific Phospholipase D

AU - Kurtz, Trisha A.

AU - Fineberg, Naomi S.

AU - Considine, Robert

AU - Deeg, Mark A.

PY - 2004/2

Y1 - 2004/2

N2 - The dyslipidemia of the metabolic syndrome is associated with alterations in triglyceride and high-density lipoprotein (HDL) metabolism. We examined the serum levels of glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD), a minor HDL-associated protein, in a cohort with a wide range of insulin sensitivity. The mean serum GPI-PLD mass from 109 subjects was 58.9 ± 18.4 μg/mL (mean ± SD). GPI-PLD levels directly correlated with cholesterol, apolipoprotein AI, triglycerides, insulin, and homeostasis model assessment (HOMA) but not C-reactive protein. These results suggest that increased serum GPI-PLD is associated with the insulin resistance.

AB - The dyslipidemia of the metabolic syndrome is associated with alterations in triglyceride and high-density lipoprotein (HDL) metabolism. We examined the serum levels of glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD), a minor HDL-associated protein, in a cohort with a wide range of insulin sensitivity. The mean serum GPI-PLD mass from 109 subjects was 58.9 ± 18.4 μg/mL (mean ± SD). GPI-PLD levels directly correlated with cholesterol, apolipoprotein AI, triglycerides, insulin, and homeostasis model assessment (HOMA) but not C-reactive protein. These results suggest that increased serum GPI-PLD is associated with the insulin resistance.

UR - http://www.scopus.com/inward/record.url?scp=0842306341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842306341&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2003.09.004

DO - 10.1016/j.metabol.2003.09.004

M3 - Article

C2 - 14767861

AN - SCOPUS:0842306341

VL - 53

SP - 138

EP - 139

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 2

ER -